The Central Government amended the Drugs Rules, 1945, expanding regulatory oversight to include advanced therapies. Cell or stem cell-derived products, gene therapeutic products, and xenografts now fall under the Central Licensing Authority (CLAA) framework.
This amendment enhances joint regulatory scrutiny by Central and State authorities for complex medical technologies and aims to standardize regulations nationwide.
Related current affairs
- Ayushman Arogya Shivir concludes across three Kartavya Bhawans in New Delhi (22–24 July 2026)
- How daily cholesterol pill holds hope for those at risk
- Expert explains: Dr Amit Roy (captioned as related to the cholesterol topic)
- E. Explained: Cigenting bacterium, what challenges remain in an anti-cancer pathway
- Centre considering to lift restrictions on airport ownership
- Govt updates on availability and strengthening of cancer care centres under NHM and related schemes